News
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets.
But, deal value has increased 3.8% overall. Fewer, bigger deals. U.S. M&A deals worth up to $500 million are down roughly 20% ...
Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...
The first thing you learn about the Manning genealogy is that those boys are some fighting SOBs, all the way back to the ...
Wall Street Zen downgraded Eli Lilly from a "buy" to a "hold" rating, signaling caution amid a flurry of mixed analyst views.
GAMMA Investing LLC increased its stake in Eli Lilly by 25.8%, now holding 18,000 shares valued at nearly $15 million. This ...
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
A fun game. Tizer [Lindgren] did a really good job behind the plate. [Coach Al] Goebel did a good job calling the pitches. It was just a good experience.” ...
Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...
Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results